Healthcare : Innovation + Job News

Two new biotechnology companies have moved to the University City Science Center's Port Business Incubator. They join the 45 other life science, healthcare IT, and emerging technologies startups currently working there. 

Targeted Therapeutic Solutions and Innolign Biomedical both launched as part of the University of Pennsylvania's UPstart Program, which develops Penn's intellectual property by helping faculty form new companies. The initiative provides participants with access to business planning, advice and support resources through collaborative relationships with entities such as the Science Center.

Targeted Therapeutic Solutions is currently developing a unique agent to reduce the incidence of stroke and bleeding for patients at risk for pulmonary embolism, deep vein thrombosis and certain types of heart attacks. Innolign Biomedical is utilizing its microfabrication technologies and tissue engineering to develop assessment platforms for the pharmaceutical industry and biomaterials to promote therapeutic tissue regeneration.

"These two new companies complement the diverse composition of the Science Center's Port incubator," says Christopher J. Laing, MRCVS, Ph.D., the Science Center’s vice president of Science and Technology. "The UPstart Program is creating an exciting pipeline of startups in biotech and emerging technologies. We are delighted to provide an ecosystem that will allow these companies to continue to grow." 

Both startups will use laboratory and office space at the Science Center for product research and development. They have each received Phase 1 Small Business Innovation Research (SBIR) funding from the National Institutes of Health.

Laing points out that with 198 hospitals and six major medical schools in the region, Philadelphia is the largest market for healthcare in the country -- which makes it a great city for startups in the field. 

"Greater Philadelphia is also home to 15 leading life science companies, and 78 have headquarters in the region," he says. "That is very important for health companies looking to establish relationships with industry."

Writer: Nicole Woods
Source: Christopher J. Laing, University City Science Center

When considering international business opportunities, investors often overlook our neighbors to the North. However, the economic development spurred by Canadian companies is quite significant. 

Vince Finn, trade commissioner of Life Sciences & Health IT at the Consulate General of Canada, estimates that bilateral trade between Canada and the U.S. nets more than $24 billion annually and contributes to 300,000 jobs in Pennsylvania.

In November, at the fifth annual eHealth Innovation Summit at the University City Science Center, eleven emerging Canadian healthcare IT companies demonstrated their technologies. These startups are part of a "market immersion" program launched by the Science Center and the Canadian Consulate General; it has been dubbed the Canadian Technology Accelerator at the Science Center (CTA for Health IT). 

The CTA for Health IT offers a communal co-working space at the Science Center’s Port Business Incubator, as well as access to programming, resources and support from the local network. Participating startups aim to build their relationships with hospitals, insurers, clinics and physicians in the city. 

The program launched in May 2013. The second group of startups took up residency at the Science Center in September 2013. Companies from both classes presented at the summit: Infonaut offers real-time clinical information about hospital infection prevention and control; Pulseinfo Frame offers database-driven informatics for disease management and clinical workflow improvement; Sensory Tech develops telemedicine solutions for in-home hospice care services; and HandyMetrics Corporation commercializes hand hygiene methods. 

Some of the participating demonstrators, including Memotext and Pulseinfo Frame, have plans to stay in Philadelphia after the immersion program is complete.

Writer: Nicole Woods
Source: Jeanne Mell, University City Science Center

A year after receiving their first certification from the Association of Analytical Communities International (AOAC), Invisible Sentinel -- the "garage" biotech startup -- is growing fast. They’re pulling in enough revenue to break-even on initial investment (over $7 million) by 2014. The company is graduating from the University City Science Center's Port Business Incubator and will remain on the Science Center campus.
 
Invisible Sentinel makes disposable, rapid diagnostic tools that test for food contaminants such as Salmonella, Listeria and Campylobacter. Veriflow, the company's patented technology, cuts down on both time and human error, making testing easier, cheaper and more reliable. Invisible Sentinel has a broad client base -- so far their products have been popular among dairy farms, peanut butter factories, meat manufacturers and third party labs that use their technology to conduct outsourced testing for large processors.
 
"Everybody who makes and produces food is our customer base," says Ben Pascal, cofounder and CBO. "It's really countrywide."
 
That means the company has a lot of work to do. They're currently outfitting and staffing an in-house manufacturing center complete with a robotics system. Open positions include manufacturing technician, quality director, production manager, financial and accounting services, sales and scientist. They will continue to raise capital for this phase.
 
"It's all expansion capital," says Pascal. "A lot of the risk associated with research and development is gone. Our challenge now is scaling to be able to meet demand."
 
Invisible Sentinel -- currently an 18-person team -- will remain in Philly thanks to low-interest government financing and flexible accommodations from the Science Center. They've received FDA approval on two products and expect approval for two more in the near future. The company recently released a video demonstrating how their devices work.
 
Source: Ben Pascal, Invisible Sentinel
Writer: Dana Henry

Thanks to a $745,000 grant from the National Science Foundation and help from an undisclosed partner, Graphene Frontiers is gearing up to produce graphene. This "super material" -- only one atom thick—is ten times stronger than diamonds and the best known conductor of electricity. In the next 18 to 24 months, Graphene Frontiers, which works out of the University City Science Center’s Port Business Incubator, expects to become one of the world first producers.
 
In order to handle the massive manufacturing startup costs, Graphene Frontiers is working with a local corporation. The partners have developed a new type of diagnostic tool -- called a field effect transistor (FET) biosensor -- that use graphene to improve how disease is detected.
 
"We've been so focused on making graphene and proving that it was possible to make it high quality," says CEO Mike Patterson. "We're not going to build a $100 million dollar facility and crank out sheets of graphene. We had to find the right application."
 
Current diagnostic devices rely on silicon wafers. The wafer contains targets for disease indicators including antibodies, antigens and other foreign chemicals. A patient's fluid sample (usually blood or urine) is applied to the microchip and disease markers bind to the targets. To confirm a diagnosis, however, doctors run multiple tests for various indicators. It’s time consuming and costly.
 
Ultra-thin graphene channels give the FET biosensor superior sensitivity. The device can test for several indicators at once and provide an instantaneous diagnosis.
 
Recently, Graphene Frontiers hired two material scientists. The FET biosensors will be created for biochemistry research departments and pharmaceutical developers. In five years, if the new device receives FDA approval, doctors and health practitioners will become the next market. One day, label-free bio-sensors could even be used at home for self-diagnosis.
 
"We can do so much with graphene," says Patterson. "The real question is what are we going to do?"
 
The University City Science Center has partnered with Flying Kite to showcase innovation in Greater Philadelphia through the "Inventing the Future" series.

Source: Mike Patterson, Graphene Frontiers
Writer: Dana Henry

DreamIt Ventures -- the Philly-based accelerator that helped launch SnipSnap and CloudMine – is tackling a particularly challenging industry: Healthcare. DreamIt Health, which launched April 8, focuses solely on companies in healthcare IT.
 
The accelerator’s first class features ten companies including AirCare, a company developed by VenturePact that helps minimize re-admissions through mobile nursing; Osmosis, a tool that helps clinicians retain vast amounts of knowledge during medical training; and Medilo, a mobile healthcare card that details benefits and eliminates the need for forms.
 
Accelerator programs like DreamIt help validate business assumptions, minimize startup risk and guide businesses to market. With healthcare startups, that process is more complex. Aside from needing to comply with changing regulations, these companies deal with a market that's behind heavy hospital doors -- data is often difficult, if not impossible, to access. DreamIt has addressed these challenges through collaborative partnerships with Penn Medicine, the region's largest provider, and Blue Cross Blue Shield, the largest insurer.

Mentoring for the nascent companies will include time with industry experts who can explain the behind-the-scenes aspects of medical operations. Each company will also receive a a stipend of up to $50,000.
 
"It's about understanding the operational systems and getting access -- potentially to the systems themselves, but also to the experts,” says Karen Griffith Gryga, managing partner at DreamIt. "We provide the payer-provider element as well as access to the operational systems, the data and other resources that are often difficult for these companies to access."
 
Companies also need to navigate conflicting interests between payers and providers. Fortunately, those parties do agree on the need for improved quality of care and tools that enable patient self-management. An app regulating daily nutritional habits, for example, could help individuals treat their diabetes or obesity. The payer and provider also share an interest in big data management systems that can help hospitals treat more people.
 
"Now, more than ever, there is this desire among the different constituents of the healthcare ecosystem to find a way to work together in a much more collaborative fashion," says Griffith Gryga. "Hopefully that will continue."
 
Source: Karen Griffith Gryga, DreamIt Ventures
Writer: Dana Henry

For health care companies completing arduous clinical trials, there's a saying that every day is worth $1 million. Completing the paperwork required to meet regulations and pay doctors can cost pharmaceutical and biotech companies quite a few extra days.
 
CFS Clinical, based in Audubon, Pa., reduces the time and money spent on forms by automating the process. Using internal proprietary software called InSite, CFS reduces "study startup" -- the time spent signing up patients and proving a site's FDA compliance -- by 20 percent. The platform also works with a global banking network to manage payments to physicians, reducing wait time from up to four months to one month.  
 
According to Kevin Williams, VP of Corporate Development, CFS is the first company to focus exclusively on the business and financial management of clinical trials. The niche has proved lucrative. CFS currently works with seven of the top 20 international pharmaceutical companies and this past year the company (founded in 2001) has grown their revenue and employee base by 50 percent. They now have 75 employees and expect to hire 10 to 15 more within the next year. Positions are available in accounting, software development and project management. 
 
CFS continues to innovate. The company recently added a "Business Intelligence" service that shows clients all their InSite transactions. Starting next year, The Sunshine Act mandates healthcare providers disclose all payment information to the federal government.

"The process of actually making payments in the clinical research world is a bit backwards," says Williams. "We make the payments on the pharmaceutical company's behalf, then we aggregate that data and provide it back to them so they can report it."
 
The payments clinical trials make to physicians -- collectively dubbed "clinical grant spend" -- cover recruiting patients, screening patients, conducting trials and collecting clinical data. Williams says this portion accounts for 40 to 60 percent of a trial's entire budget. According to the February 2011 issue of Focus, clinical grant spend leads to $13 billion in worldwide clinical trial spending. By amassing data from thousands of trials, CFS can predict this cost for individual trials.
 
"Trials, in terms of their timelines, are very volatile," says Williams. "They speed up, they slow down, they're behind, they change timelines. That has significant financial impact. We’re basically empowering our clients to control their finances much better."

Source: Kevin Williams, CFS Clinical
Writer: Dana Henry

Last Tuesday, local university research in healthcare technology got a big boost. As a third component in the StartUp PHL portfolio, the University City Science Center's QED Proof-of-Concept program -- which invests exclusively in medical research from Greater Philadelphia’s academic sector -- was awarded a $500,000 loan from Philadelphia Industrial Development Corporation (PICD) Penn Venture Fund program.
 
QED -- the abbreviated Latin phrase Quod Erat Demonstrandum (proven as demonstrated) -- provides grant money and private sector guidance to help promising studies establish early stage proof-of-concept for commercial application, a cumbersome phase of the research-to-product process. Since 2009, the program has awarded $600,000 annually, divided into $200,000 grants for life science projects and $100,000 grants for research in digital healthcare, a growing field where life science meets information technology. 

According to Stephen Tang, President and CEO of the Science Center, university settings are ideal spaces for developing broad-scope medical science, thanks to their insulation from commercial interests. A diagnostic company, for example, might build a device to detect Alzheimer's disease. Meanwhile, a university has the freedom to research the molecular identity of the disease which can inform a range of diagnostics and treatments.
 
"The theory on innovation is you have to have very divergent thinking before you have convergent thinking," says Tang. "It's that very divergent thinking that [the Science Center] is trying to tap into and help to converge on commercial opportunities."
  
Past QED participants -- representing 22 regional institutions including Penn, Drexel and the Wistar Institute -- have gone on to launch promising companies. Vascular Magnetics, producers of a drug delivery apparatus created by Dr. Robert Levy, a professor of pediatric cardiology from Children’s Hospital of Philadelphia (CHOP) and his QED business advisor Richard Woodward, recently raised $7 million in their first round of financing. UE LifeSciences Inc., a medical device company that commercialized research in breast cancer detection by  Dr. Wan Shih of Drexel's School of Biomedical Engineering, eventually received a $878,422 grant from the Pennsylvania Department Of Health's Commonwealth Universal Research Enhancement (CURE) program.
 
While the "Eds and Meds" capital has long been hailed for life science achievements, Tang sees digital healthcare as the next frontier. Thanks to the Affordable Care Act, massive amounts of medical records have to be digitized. Furthermore, the bourgeoning field of Genomics -- the science of transcribing an individual's genome to detect genetic disease -- will require terabyte-sized data transfer and manipulation. 
 
Accordingly, the 2012 QED program made awards to mobile healthcare apps developed at Rutgers University. The $500,000 PICD loan -- which is repaid via licensing royalties and revenue from successful projects -- will expand QED within city limits, boosting Philly's role in the health IT industry. 
 
"[Philadelphia] has one of the largest concentrations of healthcare facilities, hospitals and doctors, as well as academic research," says Tang. "We're betting big that that domain will distinguish Philadelphia from other metropolitan areas in the world."

The University City Science Center has partnered with Flying Kite to showcase innovation in Greater Philadelphia through the "Inventing the Future" series.

Source: Stephen Tang, University City Science Center
Writer: Dana Henry

Most know Christine Knapp as a sustainability ambassador via her outreach roles with Penn Future, the Next Great City Intiative, the Passyunk Square Civic Association and, most recently, the Philadelphia Water Department. But during Ignite Philly 11 (held last Thursday at Johnny Brenda's), Knapp gained a new title: karaoke master.

After sharing best practices from her 15 years of experience, Knapp inspired Indy Hall's Alex Hillman and Flying Kite’s Michelle Freeman to join her onstage for a rendition of Journey's "Don’t Stop Believing."
 
Such is the spirit of Ignite Philly, where local leaders put their titles aside to share their passions. Spoken word artist Erica Hawthorne gave a lively pitch for Small But Mighty Arts Grant, her mission to recover the 72 percent of art in Philly that’s gone "missing" due to lack of funding. Brett Hart of the Wooden Boat Factory explained how wood and the Delaware River are transforming the youth of his native Frankford ("This wood is like my life -- it's hard, but I’m trying to shape it into something," a student once told him). Hive76’s Jordan Miller, a Penn scientist, demonstrated how he generates living vascular structures via 3-D printing -- in sugar.
 
Ignite 11 also reflected Philly’s burgeoning love for open data. Mark Headd, the city's chief data officer, opened the evening by making a compelling analogy between Athenian Democracy and urban open data usage, warning that many Philadelphians still can't participate due to the digital divide (a problem he’s addressing with GetYourToga.org). Dave Zega and Jake Wells of ElectNext revealed their method for using data to verify the claims of politicians. Ben Garvey showed Ignite how data can be made visual -- and more digestible. And Stephanie Alarcon, Amy Gutherie and Georgia Gutherie of the Hacktory shared "Hacking the Gender Gap," a database that tracks causal experiences leading to the gender disparity in tech.
 
Other notable speakers included Amanda Feifer-O'Brien, the force behind a local movement to save beneficial micro-organisms via fermentation; Drew Beecher, president of Pennsylvania Horticultural Society and leader of a national tree-planting campaign; and Ashvika Dhir, the Pennsbury High School Senior behind CauseHub.com, a meta-blog for teenage change-makers. 
 
Ignite 11 was hosted by P'unk Ave's Geoff DiMasi, Indy Hall's Adam Teterus and Breadboard's David Clayton. They also awarded Girl Develop It Philly -- presenters at Ignite 10 -- $1000 to provide tech class scholarships for 50 local women.
 
Source: Ignite Philly 11
Writer: Dana Henry

With a rapidly growing senior population, increasingly varied insurance offerings and new regulations, the health insurance business has gotten pretty complicated. To address this, Eddystone-based Inspro Technologies offers administrative enterprise software that helps navigate those muddy waters.

"Some of these carriers could be paying 30,000 claims in a day, or more," explains Bob Oakes, CEO of Inspro. "They need to be able to handle those efficiently and quickly so that they’re not using human resources."

A new policy option for nursing care, for example, has to have a built-in structure for paying additional potential claims. The Inspro platform reduces the timeline for integrating these variations from months to weeks. Additionally, they manage applications, coordinate billing and agent commissions, and pay over 99 percent of claims. 

Inspro is currently launching a feature for managing annuities -- a situation where the insured leverages one policy, like life insurance, to pay into another, like long-term care. 

The company recently earned $2.5 million from private investors, including Blue Cross and Blue Shield, and was included in Deloitte’s "Fast 500" list for 2012. They’ve grown from 75 employees to 115 in the past year and expect to hire 40 more workers in 2013, including project managers, business analysts and Java development experts.

The company's rapid growth has attracted the attention of the Pennsylvania Department of Community and Economic Development, who recently visited their offices to study the organizational and management structure that enables the company to grow so quickly.

Source: Bob Oakes, Inspro Technologies
Writer: Dana Henry

In a 911 emergency, paramedics make life-or-death decisions in seconds. They do this without even knowing the patient's name.

This issue inspired Team My In Case of Emergency (mICE), winners of this year’s Startup Weekend Health (SWH). Their app accesses a patient's medical history, including vital information like medications and allergies, and is intended for first responders.

The grueling 54-hour hackathon, held last weekend at VentureF0rth, was largely attended by doctors, nurses and other practitioners. Sponsors included DreamIt Ventures, Safeguard and Drexel’s iSchool.

"[Clinicians] are coming up with ideas based on some of the problems they encounter every day," says Arif Virani, a SWH organizer. "It's great to get a bunch of smart people to think about these big, audacious problems and take on a tiny sliver."

mICE team leader David Bendell, a Penn nursing student and U.K. native, worked with six others, including several Penn students with backgrounds in IT or healthcare. Their winning project provides the patient's photo, identity and self-description by scanning a QR-code stored on the patient's phone. Medical records mined from insurance transactions would appear once the responder was verified by the insurance company's call center.

A total of 90 people participated in SWH, providing 36 pitches. There were 20 front-runners and 13 made it to the final demo round. In second place was Jose Morey, a radiologist at Penn, and his team USmedics, who created a platform that enables remote patients -- particularly those outside the United States -- to have test results read by doctors at top hospitals. Finishing third was KnowMe, an app conceptualized by Penn nursing student, Kerry McLaughlin, that helps nursing home staff maintain daily records of residents' moods, symptoms and habits.

Lon Hect, the winner of last year’s SWH, went on to win the Independence Blue Cross Game Changers Challenge and was awarded $50,000 in seed money. He is currently working on his startup full-time.

Source: Arif Virani, David Bendell, Startup Weekend Health
Writer: Dana Henry

In 2010, a Cornell University-led research team made a technological breakthrough: Tiny beams of light reached into a microscope slide and grabbed a cellular protein without significantly altering the protein’s environment. Scientists were already capable of grasping a whole cell using optical tweezers, but a protein is up to 5,000 times smaller and in constant rapid motion—it’s also critical to our understanding of physiology and disease.
 
Thanks to Optofluidics, research labs will finally be able to pin down this elusive element. The company, a tenant of the University City Science Center, licenses Cornell’s technology and is currently marketing the "Molecular NanoTweezer." They will launch their product within six months, and are hiring a nanobiotech applications engineer.
 
According to Rob Hart, co-founder and chief technical officer at Optofluidics, commercializing a new technology is a "heck of a lot of work." In the confines of the academic laboratory, a ten percent success rate is considered an achievement. The real world, however, is a far messier place, and a marketable product needs to work consistently.
 
Optofluidics partnered with NextFab Studio on a range of custom parts and developed their system design in conjunction with Horsham-based Avo Photonics. They’ve accumulated $580,000 in private investment from the Ben Franklin Nanotechnology Institute and BioAdvance, along with $1.5 million in federal and foundation grants.
 
Nanotechnology has broad implications for the spectrum of scientific research--it can be used to make new medicines, create more efficient solar panels or build better bike frames. For health sciences, the Molecular NanoTweezer enables the increasingly popular field of single-molecule research. "It sounds advanced because it is," says Hart. "It’s a really cutting edge way of moving things around."
 
According to Hart, pharmaceutical companies and several large universities, including Drexel, Penn, Princeton and Cornell, have expressed interest in purchasing the product upon it’s release.

Source: Rob Hart, Optofluidics
Writer: Dana Henry

Twenty years of research and clinical trials led to the recent announcement that 7-year-old Emma Whitehead's luekemia was in remission. It was the moment that T-cell immunotherapy technology burst from the laboratories of Penn Medicine into the national headlines. Now a commitment from Novartis to build a $20 million Center for Advanced Cellular Therapy (slated for 2013) will speed up FDA approval and enable treatment in greater numbers.

For something as large and complex as cancer research, philanthropic and federal funding only goes so far. "We’re so fortunate to have the opportunity, with this alliance with Novartis, to hand off what we’ve developed in an academic medical center," says Bruce Levine, director of the Clinical Cell and Vaccine Production Facility at Penn's Abramson Cancer Center.

Just how big is the breakthrough?

The Penn team is already building t-cell programs to treat pancreatic cancer, breast cancer and prostate cancer. Eventually, this treatment could affect tens of thousands of lives.

Understandably, Penn medicine has been deluged with calls from patients worldwide. In an effort to coordinate a response, the Ambrason Cancer Center has launched a separate section on their website for access to detailed trial information, physicians and additional clinical trials.
 
It’s hard to measure the full impact T-cell immunotherapy will have on economic growth for our region, but Levine anticipates a "ripple effect." In addition to the construction, staffing and management jobs necessary for a $20 million facility, a greater number of clinical trials leads to more opportunities for care providers and researchers. For now, Penn Medicine’s technical groups are offering highly skilled positions while Novartis builds up their expertise.

"It’s huge," says Levine. "We’ve seen from [Penn] University and Penn Medicine a great commitment to facilitating this research." 

Source: Bruce Levine, Penn Medicine
Writer: Dana Henry

On the heels of the passage of Pennsylvania’s Act 152, Joanne Lang, founder and CEO of AboutOne, is leading the way for local B-corporations. The company, which developed an app that simplifies access to an individual’s health records and other vital documents, has reached over 100,000 caregivers and is now tackling a brand new challenge—the Department of Human Services.  

The Communication Station is AboutOne’s co-brand for guardians of foster children. Nationally, there are over 600,000 children in foster care. Because most of these children change families multiple times, tracking health, education and even personal memories is a challenge. The Communication Station will provide a private place for those files and motivate foster parents to store important documents with gift vouchers. The platform is particularly enticing for state governments—they are now federally mandated to furnish medical data for foster children when they turn 18.

"We can save [social services] months of time and money meeting their legal requirements by providing that information for them," says Lang. "We have to take small steps and get this version working. In the longer term, we can use it to grow the company because we will have a proven solution to sell to states and cities all over the USA."

The new brand has received an endorsement from Mayor Nutter and DHS Commissioner Anne Marie Ambrose. The Child Welfare League of America is already organizing a consortium of municipal and state clients. Lang expects to pilot The Communication Station for The City of Philadelphia and is reaching out for crowd funding through IndieGoGo.

"The Communication Station needs some special features and a special game design," she explains. "We can’t fund this co-brand by ourselves. I had a choice: sit and wait, or do what I do best as an entrepreneur—overcome barriers, think of new and lateral ways to fund this small pilot quickly, and move forward."

Since launching over a year ago, AboutOne has grown their staff by 300 percent and signed with larger caregiving businesses. Lang, who is also a mother of four sons, was recently selected for Dell’s Founders Club. Despite her national ambitions, Lang says she’s determined to stay in Philadelphia, and credits Mayor Nutter and Philadelphia Startup League for helping so many grow their dreams.

"A woman in technology—with children—can grow a startup company here in PA and be successful here in PA," she says. "You don’t need to move to Silicon Valley or anywhere else."

Source: Joanne Lang, AboutOne
Writer: Dana Henry 

Tech incubator Dreamit Ventures has announced its Fall 2012 Philadelphia lineup. Moving three blocks up the street to 3701 Market Street but still at the University City Science Center, Managing Partner Karen Griffith Gryga says Dreamit will be leveraging its proximity to the Science Center's Quorum.

"There is a great deal of programming planned for this class," says Gryga. "In addition to the one-on-one mentoring that we establish for the companies based on their particular needs and the frequent meetings with the DreamIt partners, we have speakers from leading VC firms, leading industry players and operational experts as well as workshops on technologies and operational components. We have investor office hours with ventures capitalists from across the country as well as angel investors."

Gryga places a high value on accelerator participants' interactions with each other,and reports that Dreamit will hold more regular social events to add some fun to the mix.
 
Speaking of fun, this year, recipes and bridesmaids dresses are the focus of two companies. "The entrepreneurial team is the critical decision area and less so the idea because we know that with the right team we can always refine or reformulate a market/customer centric solution.  Over the years, we have had many consumer facing opportunities and, in fact, had both Bazaart and TopShelf in the New York program this summer and KeepRecipes the New York summer before."
 
As in years past, the Dreamit teams come to Philadelphia from locations worldwide. Five of the companies are part of the DreamIt Access program, a dedicated effort to launch 15 minority-led startups over the next 12 months. Comcast Ventures is an investor in the DreamIt Access program.  Here's a detailed listing of this year's companies.
 
The 14 startups in the program are:
 
- Altair Prep, Philadelphia:  Performance-based homework platform that analyzes learning trends and customize curricula
- Applique, New York, NY:  Drag-and-drop ease for building iPhone and iPad Apps
- Betterific, Washington, DC:  Crowdsourcing platform aims to improve products and brands by allowing consumers to submit ideas and suggestions
- brandREP.me, Los Angeles, CA:  Crowdsources brand marketing campaigns to student
- Brideside, Chicago, IL:  Oline boutique for bridesmaids dresses.
- CallGrader, Denver, CO:  Marketing analytics and rich data for phone calls
- Charlie, Chicago, IL:  Mobile app provides vital contact information whenever you need it
- CloudConfidence, Philadelphia:  Platform for analytics-driven cloud monitoring and management
- FlagTap, San Francisco, CA:  On-site rewards that are easy to manage
- mor.sl, Washington, DC:  Recipe recommendation platform that personalizes based on tastes, cooking skill and allergies
- Peeractive, Sydney, Australia:  Social commerce technology with real-time analytics 
- The Whoot, New York, NY:  Short-term social planning
- Tripkno, New York, NY:  Travel guide incorporates social and e-commerce to help people find things to do
- Zenkars, Philadelphia:  Online used car retailer

Source: Karen Griffith Gryga, Dreamit Ventures
Writer: Sue Spolan